| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,369 |
28,994 |
$2.13M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,388 |
10,335 |
$1.06M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,709 |
9,702 |
$893K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,401 |
10,361 |
$381K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,427 |
9,357 |
$263K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,953 |
13,900 |
$199K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,159 |
1,159 |
$159K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
207 |
206 |
$9K |
| 87807 |
|
833 |
826 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
100 |
100 |
$6K |
| 87430 |
|
398 |
396 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
118 |
118 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
164 |
164 |
$2K |
| 87400 |
|
117 |
117 |
$1K |
| 81025 |
|
157 |
156 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
29 |
$253.53 |
| 81003 |
|
18 |
17 |
$34.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
43 |
43 |
$1.82 |